期刊文献+

晚期卵巢恶性肿瘤理想细胞减灭术的可行性 被引量:1

The feasibility of optimal cytoreductive surgery in advanced malignant tumors of ovary
暂未订购
导出
摘要 对22例国际妇产科协会(FIGO)Ⅲ、Ⅳ期卵巢恶性肿瘤患者行手术治疗,其中初次手术13例,再次手术9例,手术范围涉及生殖、消化、泌尿等系统,达到理想细胞减灭术(残余肿瘤≤2cm)16例,经短期(2~14月)随访,无复发.未达理想者6例,预后差.术后残余肿瘤>2cm的部位主要是盆腔的肿瘤粘连,其次为胃结肠韧带、肝门和牌门.此外,还对细胞减灭术的意义、手术可行性及影响手术彻底性的因素进行了讨论. <Abstract >Prom January 1991 to March 1992,22 patients with FIGO of stage III and IV ovariancancer underwent surgical treatment. The optimal one was considered when the residual lesion was lessthan 2 cm after operation. The metastatic foci great than 2 cm before resection occured primarily in theomentum, pelvis and colon. 16 in 22 patients received optimal cytoreductive operation. The residual le-sions great than 2 cm were located in pelvis ,gastrocolic,hepatic and splenic hilus. With short time follow-up,16 patients with optimal operations are all alive without recurrences. In contrast,6 patients withunsatisfactory operation are in bad conditions. The authors expressed their own opinions on surgicalprinciples, demand, management, feasibility of the operation and the factors affecting cytoreductive surgery.
作者 李春荣
出处 《海军总医院院刊》 1994年第4期236-239,共4页
关键词 肿瘤细胞减灭术 卵巢肿瘤 治疗 <Keyword>Qvarian neoplasms cytoreductive surgery
  • 相关文献

同被引文献12

  • 1Arikan SK, Kasap B, Yetimalar Het al. Impact of prognostic factors on survival rates in pa!ients with ovarian carcinoma [J]. Asian Pac J Cancer Prey,2014,15(15):6087-6094.
  • 2Pereira A,Prrez-Medina T,Magrina JF,et al. Correlation between the extent of intraperitoneal disease and nodal metastasis in node-positive ovarian cancer patients[J]. Eur J Surg Oncal,2014,40(8):917-924.
  • 3Lin JE,Seo S,Kushner DM,et al.The role of appendecto- my for mucinous ovarian neoplasms [J]. Am J Obstet Gy- necol, 2013,208(1) : 46.e l-e4.
  • 4Fontanclli R,Paladini D,Raspagliesi F,et al.The role of appendectomy in surgical procedures for ovarian cancer[J]. Gynecol Oncol, 1992,46(1) :42-44.
  • 5Panici PB,Maggioni A, Hacker N,et al.Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian can- cer:a randomized clinical trial [J]. J Natl. Cancer Inst, 2005,97(8) : 560-566.
  • 6Berek JS. Lymph node positive stage ]]I C ovarian cancer a separate entity?[J].Int J Gynecol Cancer, 2009,19 :S 18-$20.
  • 7Chan JK,Manro EG,Cheung MK,et al. Association of lymphadenectomy and survival in stage I ovarian cancer patients[J]. Obstet Gyneco1,2007,109(1) : 12-19.
  • 8Aletti GD,Dowdy S,Podratz KC,et al. Role of lym- phadenectomy in the management of grossly apparent ad- vanced stage epithelial ovarian eancer[J].Am J Obstet Gy- necol, 2006, 195(6) : 1862-1868.
  • 9Tewari D,Java JJ,Salani R,et al. Long-term survival ad- vantage mad prognostic factors associated with intraperi- toneal chemotherapy treatment in advanced ovarian can- cer:a gynecologic oncology group study [J].J Clin Oncol, 2015,23 : 1000-1005.
  • 10Buys SS,Partridge E,Black A,et al. Effect of screening on ovarian cancer mortality:the Prostate,Lung,Colorec- tal,and Ovarian (PLCO) Cancer Screening Randomized Controlled trial[J]. JAMA, 2011,305 : 2295-2303.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部